Dan Rudio

Dan Rudio is the Chief Financial Officer at Uniquity Bio, with a background in finance and accounting spanning over two decades. Prior to his current role, Dan held various positions at CFGI, Endo Pharmaceuticals, Rohm and Haas, and Ernst & Young LLP. He holds a BS in Accounting & Finance from Rutgers University - Camden.